Skip to main content
Erschienen in: Trials 1/2020

Open Access 30.06.2020 | COVID-19 | Letter

Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol

verfasst von: Marco Marietta, Paola Vandelli, Pasquale Mighali, Roberto Vicini, Valeria Coluccio, Roberto D’Amico, on behalf of COVID-19 HD Study Group

Erschienen in: Trials | Ausgabe 1/2020

download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol
verfasst von
Marco Marietta
Paola Vandelli
Pasquale Mighali
Roberto Vicini
Valeria Coluccio
Roberto D’Amico
on behalf of COVID-19 HD Study Group
Publikationsdatum
30.06.2020
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
Trials / Ausgabe 1/2020
Elektronische ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04475-z

Weitere Artikel der Ausgabe 1/2020

Trials 1/2020 Zur Ausgabe